1. Home
  2. FTHM vs HBIO Comparison

FTHM vs HBIO Comparison

Compare FTHM & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

N/A

Current Price

$0.72

Market Cap

28.8M

Sector

Finance

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$7.48

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHM
HBIO
Founded
2010
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.8M
26.5M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
FTHM
HBIO
Price
$0.72
$7.48
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$2.50
$18.00
AVG Volume (30 Days)
134.4K
18.1K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
32.71
N/A
EPS
N/A
N/A
Revenue
$420,477,000.00
$116,176,000.00
Revenue This Year
$11.67
$4.77
Revenue Next Year
N/A
$8.55
P/E Ratio
N/A
N/A
Revenue Growth
25.45
N/A
52 Week Low
$0.40
$0.38
52 Week High
$3.37
$7.63

Technical Indicators

Market Signals
Indicator
FTHM
HBIO
Relative Strength Index (RSI) 41.21 70.10
Support Level $0.70 $5.91
Resistance Level $0.92 $7.50
Average True Range (ATR) 0.06 0.36
MACD -0.00 0.12
Stochastic Oscillator 10.67 86.73

Price Performance

Historical Comparison
FTHM
HBIO

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: